Centre for Cell Factories and Biopolymers (CCFB)
Griffith University’s Institute for Biomedicine and Glycomics
The Centre for Cell Factories and Biopolymers, hosted within Griffith University’s Institute for Biomedicine and Glycomics, researches and develops innovative functional materials and technologies that can provide solutions for global health and environmental challenges. We harness the capacity of diverse biological systems to synthesise and assemble biologically active materials by applying bioengineering, synthetic biology and biotechnological approaches. A major research focus of ours is the design and development of innovative bio-based materials for uses as vaccines and in diagnostics. Disease focus areas are bacterial, viral and parasite infections such as those caused by Mycobacterium tuberculosis, Pseudomonas aeruginosa, Streptococcus A , Hepatitis C virus, Chikungunya virus and the malaria causing parasite Plasmodium faciparum.
- Website
- https://www.griffith.edu.au/institute-drug-discovery/our-institute/cell-factories-biopolymers
- Organisation type
- University research centre
- Number of research staff
- Up to 20 research staff
- Address
- Griffith Institute for Biomdeicine and Glycomics (N75), Don Young Road, Griffith University, Nathan QLD 4111
Strengths and capabilities
- Biomolecular engineering
- Bioproduction
- Hybrid biomaterials
- Biopolymers
- Vaccines
- Biotechnology
- Microbial expression
- Plant-based expression
- Bioprocessing
- Microbiology
Facilities and major equipment
- Microbial fermentation bioreactor suite
- Bioprocess development
- Biomaterials characterization
- Physical Containment Class 2 (PC2) laboratory
- Biopolymer analysis unit
- Protein analysis unit
- Plant genetic and molecular laboratories
- Immunology and cell culture laboratories
Lead researchers
- Professor Bernd Rehm—Developed biomaterials platform technologies for precision-engineering of vaccines, diagnostics, biocatalysts and bioseparation resins.
- Dr Frank Sainsbury—Developed expression technologies that have supported Phase III clinical trials for VLP vaccines.
Achievements of the centre
- Development of vaccine candidates against SARS-CoV-2
- Development of vaccine candidates against malaria
- Development of innovative self-assembling hybrid biomaterials
Key science sectors
More information about the sectors this centre is involved in:
Update details
Is this your centre? See any issues? Send a request to update your listing.